EUVIMEDEUVIMED entdecken
Crossref

Advancement of Heart Transplantation in Thai Recipients: Survival Trends and Pharmacogenetic Insights

Siwaporn Manomaisantiphap, Pasawat Boon-Yasidhi, Napatsanan Tanathitiphuwarat, Kanokwan Thammanatsakul, Sarinya Puwanant iD, Akekarach Ariyachaipanich, Supanee Sinphurmsukskul, Monvasi Pachinburavan, Pajaree Chariyavilaskul iD, Sarawut Siwamogsatham iD, Pat Ongcharit

Clinical Transplantation · 2025

DOI: 10.1111/ctr.70092 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Transplantation, 2025. Verfasst von Siwaporn Manomaisantiphap und 10 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Department of Pharmacology, Chulalongkorn University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Graft Rejection, Heart Transplantation, Immunosuppressive Agents, Pharmacogenetics. Die Arbeit nennt 25 Literaturangaben. Gefördert von: Thailand Science Research and Innovation Fund, Chulalongkorn University, Health Systems Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since 1987, King Chulalongkorn Memorial Hospital (KCMH) has performed a substantial number of heart transplants as a specific therapy for advanced‐stage heart failure. This descriptive study aimed to analyze post‐transplant survival in the recent era compared to earlier periods and examine the pharmacogenetics of related immunosuppressants. Data from all recipients who underwent heart transplants from 1987 to 2021 were retrospectively retrieved from the electronic medical record. The genotypes of relevant pharmacogenes were analyzed in recipients who were alive during the enrollment period. Kaplan–Meier analysis revealed improved overall survival rates in the recent era compared to the past. Dilated cardiomyopathy was identified as the most common pretransplant diagnosis, while infection remained the leading cause of mortality. In conclusion, the findings demonstrate significant advancements in the quality of heart transplantation in Thailand. Future studies are warranted to explore the correlation between pharmacogenetic variations identified in this study and subsequent clinical outcomes, with a focus on genetic‐guided treatment to optimize patient care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft RejectionHeart TransplantationImmunosuppressive AgentsPharmacogeneticsPostoperative ComplicationsTransplant RecipientsAdultFemaleHumansMaleMiddle AgedFollow-Up StudiesGraft SurvivalHeart FailurePrognosisRetrospective StudiesRisk FactorsSoutheast Asian PeopleSurvival RateThailand

Stichwörter der Autor:innen

heart transplantationheart–lung transplantationpharmacogeneticssurvival

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Faculty of Medicine, Department of Pharmacology, Chulalongkorn University, Bangkok, Thailand.
  • Center of Excellence in Clinical Pharmacokinetics and Pharmacogenomics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Excellence Center for Organ Transplantation, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.
  • Faculty of Medicine, Division of Cardiovascular Medicine, Department of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Cardiac Center, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.
  • Faculty of Medicine, Division of Critical Care Medicine, Department of Medicine, Chulalongkorn University, Bangkok, Thailand.

ORCID-Profile: Sarinya Puwanant, Pajaree Chariyavilaskul, Sarawut Siwamogsatham

Förderung

  • Thailand Science Research and Innovation Fund
  • Chulalongkorn University
  • Health Systems Research Institute
  • Ratchadapisek Somphot Fund
  • Faculty of Medicine, Chulalongkorn University

Zitieren

APA

Manomaisantiphap, S., Boon-Yasidhi, P., Tanathitiphuwarat, N., Thammanatsakul, K., Puwanant, S., Ariyachaipanich, A., Sinphurmsukskul, S., Pachinburavan, M., Chariyavilaskul, P., Siwamogsatham, S., & Ongcharit, P. (2025). Advancement of Heart Transplantation in Thai Recipients: Survival Trends and Pharmacogenetic Insights. Clinical Transplantation. https://doi.org/10.1111/ctr.70092

Vancouver

Manomaisantiphap S, Boon-Yasidhi P, Tanathitiphuwarat N, Thammanatsakul K, Puwanant S, Ariyachaipanich A, et al. Advancement of Heart Transplantation in Thai Recipients: Survival Trends and Pharmacogenetic Insights. Clinical Transplantation. 2025. doi:10.1111/ctr.70092

BibTeX
@article{Manomaisantiphap2025,
  author = {Manomaisantiphap, Siwaporn and Boon-Yasidhi, Pasawat and Tanathitiphuwarat, Napatsanan and Thammanatsakul, Kanokwan and Puwanant, Sarinya and Ariyachaipanich, Akekarach and Sinphurmsukskul, Supanee and Pachinburavan, Monvasi and Chariyavilaskul, Pajaree and Siwamogsatham, Sarawut and Ongcharit, Pat},
  title = {Advancement of Heart Transplantation in Thai Recipients: Survival Trends and Pharmacogenetic Insights},
  journal = {Clinical Transplantation},
  year = {2025},
  doi = {10.1111/ctr.70092}
}
Kostenlos starten →